Floatz logo

Deferasirox

Anemia, Diamond-Blackfan

NovartisSmall moleculePhase 4 / ApprovedDormant
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
63/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Anemia, Diamond-Blackfan cohort.

Asset / SponsorPhaseRating
Fludarabine
Fred Hutchinson Cancer Center
Phase 2/3BBB
Busulphan
Paul Szabolcs
Phase 2/3BBB
Cyclophosphamide
Paul Szabolcs
Phase 2/3BB
Thiotepa
Fred Hutchinson Cancer Center
Phase 2BB
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2BB

View all 24 →

Same molecule, other indications

Deferasirox is also rated in:

iron poisoningDormant
A
Indicative ·
82 / 100
View asset →
hemosiderosisDormant
A
Indicative ·
81 / 100
View asset →
beta-thalassemia majorDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →